Inhibition of soluble TNFa in conjunction with anti‐amyloid immunotherapy
Inhibition of sTNFα is promising as a potential combination therapy with anti-Aß antibodies for reduction of systemic inflammation and microhemorrhage development, supporting future studies exploring this target.
Authors
- Erica M. Weekman (ORCID: https://orcid.org/0000-0003-1252-6547)
- Joshua Lykins (ORCID: https://orcid.org/0009-0002-9276-0092)
- Hsin‐Pei Wang
- Katelynn E. Krick
- Donna M. Wilcock
Institutions
- Neurosciences Institute (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70855_107693
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00